Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.
作者信息
Cant J S, Lewis D R
出版信息
Br J Ophthalmol. 1969 Apr;53(4):239-45. doi: 10.1136/bjo.53.4.239.
Abstract
摘要
相似文献
1
Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.
Br J Ophthalmol. 1969 Apr;53(4):239-45. doi: 10.1136/bjo.53.4.239.
2
Dysthyroid eye disease. A trial of guanethidine eye drops.
Br J Ophthalmol. 1969 Apr;53(4):246-51. doi: 10.1136/bjo.53.4.246.
3
Treatment of dysthyroid ophthalmopathy with local guanethidine.
Br J Ophthalmol. 1969 Apr;53(4):233-8. doi: 10.1136/bjo.53.4.233.
4
[Effect of guanethidine eyedrops on the ocular manifestations of Basedow's disease].
Arch Ophtalmol Rev Gen Ophtalmol. 1971 Aug-Sep;31(8):617-28.
5
Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.
Br Med J. 1969 Dec 13;4(5684):645-7. doi: 10.1136/bmj.4.5684.645.
6
[Action of 5 per cent guanethidine sulfate (ismeline) eye drops on lid retraction during Basedow's disease].
Ann Ocul (Paris). 1971 Jun;204(6):627-44.
7
[Ocular manifestations of Basedow's disease and local administration of guanethidine].
Presse Med (1893). 1971 Jan 16;79(3):83-6.
8
Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.
Br Med J. 1967 Dec 9;4(5579):592-5. doi: 10.1136/bmj.4.5579.592.
9
Topical guanethidine therapy for endocrine lid retraction.
Arch Ophthalmol. 1966 Sep;76(3):364-7. doi: 10.1001/archopht.1966.03850010366012.
10
Use of guanethidine eye drops in dysthyroid lid retraction.
Proc R Soc Med. 1969 Jan;62(1):18-9. doi: 10.1177/003591576906200111.
引用本文的文献
1
Nonsurgical management of upper eyelid retraction in thyroid eye disease.
Taiwan J Ophthalmol. 2023 May 23;14(4):548-553. doi: 10.4103/tjo.TJO-D-23-00043. eCollection 2024 Oct-Dec.
2
Update on the surgical management of Graves' orbitopathy.
Front Endocrinol (Lausanne). 2023 Feb 6;13:1080204. doi: 10.3389/fendo.2022.1080204. eCollection 2022.
3
Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.
Br Med J. 1969 Dec 13;4(5684):645-7. doi: 10.1136/bmj.4.5684.645.
本文引用的文献
1
Guanethidine (Ismelin) in ophthalmology. II. Clinical application in glaucoma.
Arch Ophthalmol. 1962 Jun;67:802-10. doi: 10.1001/archopht.1962.00960020802016.
2
Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.
Br Med J. 1967 Dec 9;4(5579):592-5. doi: 10.1136/bmj.4.5579.592.
3
Topical sympatholytic therapy for pathologic lid retraction.
Arch Ophthalmol. 1967 Mar;77(3):341-4. doi: 10.1001/archopht.1967.00980020343009.
4
Topical guanethidine therapy for endocrine lid retraction.
Arch Ophthalmol. 1966 Sep;76(3):364-7. doi: 10.1001/archopht.1966.03850010366012.
5
Treatment of dysthyroid ophthalmopathy with local guanethidine.
Br J Ophthalmol. 1969 Apr;53(4):233-8. doi: 10.1136/bjo.53.4.233.
6
Adrenergic blockade and the eye signs of thyrotoxicosis.
Lancet. 1966 Sep 3;2(7462):525-7. doi: 10.1016/s0140-6736(66)92881-9.
Zotero 插件